Prognostic factors and outcome analysis of soft tissue sarcomas of the head and neck region.
N. R. Khanna, S. Ghosh Laskar(Tata Memorial Hospital), M.A. Muckaden(Homi Bhabha National Institute), DA Chaukar(Tata Memorial Hospital), Asawari Patil(Tata Memorial Hospital), Saurabh Gupta, AK D′Cruz(Tata Memorial Hospital), Prathamesh Pai(Tata Memorial Hospital), NA Jambhekar, Gurusha Bahl(Tata Memorial Hospital)
Cited by 0
Related Papers
Once-a-Week Versus Once-Every-3-Weeks Cisplatin Chemoradiation for Locally Advanced Head and Neck Cancer: A Phase III Randomized Noninferiority Trial
|Journal of Clinical Oncology|2017|340
Consolidation Radiation After Complete Remission in Hodgkin's Disease Following Six Cycles of Doxorubicin, Bleomycin, Vinblastine, and Dacarbazine Chemotherapy: Is There a Need?
|Journal of Clinical Oncology|2003|202
Hypofractionated, palliative radiotherapy for advanced head and neck cancer
|Radiotherapy and Oncology|2008|124